Clinical Pearls in Infectious Disease
Craig Worby, PharmD
Jamie Godin, PharmD
Karen Michaud, PharmD
2. List appropriate drug therapy and potential barriers to treatment initiation for toxoplasmosis
3. Describe the role of bezlotoxumab for secondary prevention of C. difficile infection
Registration and Cash Bar start at 6 pm.
Dinner and Program start at 6:30 pm.
Please feel free to display the flyer or forward to anyone interested.
Spring Dinner Program 2017
We look forward to seeing you all there!
NHSHP Board of Directors
READING YOUR CE CERTIFICATES
New Hampshire Society of Health System Pharmacists
Email us at email@example.com